Evidence map›Paper›PMID 27169854›Full record

ReviewMicrobiology and molecular biology reviews : MMBR2016

The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases.

Ioanna Petta, Lien Dejager, Marlies Ballegeer, Sam Lievens, Jan Tavernier, Karolien De Bosscher, Claude Libert

Open access · bronzeAbstract readReview
In one paragraph

Review in Microbiology and molecular biology reviews : MMBR, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 116 papers.

0numbers the graph read from it
0cells of the map it votes in
116citing papers in PubMed
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

116 citing papers in PubMed, 195 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Observational
  20. The Role of Scavenger Receptor BI in Sepsis.International journal of molecular sciences · 2024
    Review

56 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ioanna PettaReceptor Research Laboratories, Cytokine Receptor Lab, Medical Biotechnology Center, VIB, Ghent, Belgium Department of Biochemistry, Ghent University, Ghent, Belgium Inflammation Research Center, VIB, Ghent, Belgium Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Lien DejagerInflammation Research Center, VIB, Ghent, Belgium Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Marlies BallegeerInflammation Research Center, VIB, Ghent, Belgium Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Sam LievensReceptor Research Laboratories, Cytokine Receptor Lab, Medical Biotechnology Center, VIB, Ghent, Belgium Department of Biochemistry, Ghent University, Ghent, Belgium.
Jan TavernierReceptor Research Laboratories, Cytokine Receptor Lab, Medical Biotechnology Center, VIB, Ghent, Belgium Department of Biochemistry, Ghent University, Ghent, Belgium.
Karolien De BosscherReceptor Research Laboratories, Cytokine Receptor Lab, Medical Biotechnology Center, VIB, Ghent, Belgium Department of Biochemistry, Ghent University, Ghent, Belgium Receptor Research Laboratories, Nuclear Receptor Lab, Medical Biotechnology Center, VIB, Ghent, Belgium karolien.debosscher@vib-ugent.be.
Claude LibertInflammation Research Center, VIB, Ghent, Belgium Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
Ghent University · BEVIB-UGent Center for Inflammation Research · BEVIB-UGent Center for Medical Biotechnology · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glucocorticoids (GCs) have been widely used for decades as a first-line treatment for inflammatory and autoimmune diseases. However, their use is often hampered by the onset of adverse effects or resistance. GCs mediate their effects via binding to glucocorticoid receptor (GR), a transcription factor belonging to the family of nuclear receptors. An important aspect of GR's actions, including its anti-inflammatory capacity, involves its interactions with various proteins, such as transcription factors, cofactors, and modifying enzymes, which codetermine receptor functionality. In this review, we provide a state-of-the-art overview of the protein-protein interactions (PPIs) of GR that positively or negatively affect its anti-inflammatory properties, along with mechanistic insights, if known. Emphasis is placed on the interactions that affect its anti-inflammatory effects in the presence of inflammatory and microbial diseases.

Indexed as

AnimalsAnti-Inflammatory AgentsCell NucleusCommunicable DiseasesGlucocorticoidsHumansInflammationProtein Interaction MapsProtein Processing, Post-TranslationalReceptors, GlucocorticoidSignal TransductionSTAT Transcription FactorsTransforming Growth Factor betaAnti-Inflammatory AgentsGlucocorticoidsReceptors, GlucocorticoidSTAT Transcription FactorsTransforming Growth Factor beta

Identifiers

PMID27169854
PMCPMC4867367
OpenAlexW2353444611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.